About Imbrium Therapeutics
Imbrium Therapeutics is a Healthcare company based in Stamford (United States) founded in 2019. It develops novel therapeutics for CNS, oncology, and non-opioid pain via partnerships and pipelines. It operates on a B2B model. Imbrium Therapeutics offers products and services including Pipeline Therapies. Its focus areas include Biopharmaceuticals, Drug Development, CNS Therapies and Oncology Chemotherapeutics. Its legal entity is Imbrium Therapeutics L.P. Its competitors include Apnimed and Somnus Therapeutics; 2 of its 2 listed competitors have raised funding.
Company details
Imbrium Therapeutics is a clinical-stage biopharmaceutical company focused on advancing medical science by creating new therapeutics for serious conditions such as CNS disorders, oncology, and non-opioid pain management. They build a diversified pipeline of investigational candidates and collaborate with commercial and academic partners to address unmet patient needs. Based in Stamford, CT, they emphasize innovation in drug development programs without direct consumer sales.
- Headquarters Stamford, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website imbriumthera.com
- Social LinkedIn X
- Legal Name Imbrium Therapeutics L.P.
Products & Services of Imbrium Therapeutics
Imbrium Therapeutics offers a comprehensive portfolio of products and services, including Pipeline Therapies.
Develops candidates for CNS, oncology, and pain treatments through research
People of Imbrium Therapeutics
155 people are tracked at Imbrium Therapeutics (75 in leadership, 80 in team).
| Name | Role | Group |
|---|---|---|
Jay Butler | Associate Director, Operational Excellence | Leadership |
Edward Mahony | EVP & Chief Financial Officer | Leadership |
David Ward | Director Of Operations | Leadership |
Kathleen Senter | Associate Director Supply Chain | Leadership |
Debi Fasanella | Director, Chargeback Operations | Leadership |
John P. Gilbride | Director Ethics And Compliance | Leadership |
Craig Landau | President & CEO | Leadership |
Roxana Aleali | Vice President, General Counsel And Secretary | Leadership |
Kurt Haase | Director Of Infrastructure And Collaboration Services | Leadership |
Dr. Anu Raina | Director, Information Technology - Business Relationship Partner | Leadership |
Diego Munoz | Associate Director Of Operations | Leadership |
Hussein Ghnaimeh | VP Information Technology, CIO | Leadership |
Mike Ronning | Vice President, Sales & Marketing | Leadership |
Jungeun Lee | Fp&a Associate Director, Research And Development & Medical Affairs | Leadership |
Val Pascale | Medical Director - Product, Pipeline & Strategy | Leadership |
Jason Hodges | Director, Market Research And Field Operations | Leadership |
Brian Sullivan | Associate Director, R&d Systems | Leadership |
Abraham H. | Associate Director Tech Ops IT Systems | Leadership |
Robert Kupper | VP & CSO | Leadership |
Juan Diego Alonso | Director, Ethics & Compliance | Leadership |
135 more people are available in the full profile.
Complete people profiles for Imbrium Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Imbrium Therapeutics
Imbrium Therapeutics has 2 listed competitors in our database, 2 of them funded. They include Apnimed and Somnus Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| apnimed.com | 2017 | Cambridge, United States | $224.33M | Small molecule therapeutics for obstructive sleep apnea are developed. | ||
| somnusthera.com | 2007 | Bedminster, United States | $15M | Controlled-release sleep maintenance therapeutics are developed by the company. |
Detailed competitors of Imbrium Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Imbrium Therapeutics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Imbrium Therapeutics
Complete news archive for Imbrium Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imbrium Therapeutics
Imbrium Therapeutics was founded in 2019.
Imbrium Therapeutics is headquartered in Stamford, United States. It is registered at Stamford, Connecticut, United States.
Imbrium Therapeutics is a clinical-stage biopharmaceutical company focused on advancing medical science by creating new therapeutics for serious conditions such as CNS disorders, oncology, and non-opioid pain management. They build a diversified pipeline of investigational candidates and collaborate with commercial and academic partners to address unmet patient needs. Based in Stamford, CT, they emphasize innovation in drug development programs without direct consumer sales.
Imbrium Therapeutics's top competitors include Apnimed and Somnus Therapeutics.
Imbrium Therapeutics offers Pipeline Therapies.
Imbrium Therapeutics operates through Imbrium Therapeutics L.P..